Work

Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction

Year: 2015

Type: article

Source: Biomaterials

DOI: 10.1016/j.biomaterials.2014.12.021

Authors: Sonya B. Sonnenberg, Aboli A. Rane, Cassie J. Liu, Nikhil Rao, Gillie Agmon, Sophia Suarez, Raymond Wang, Adam Munoz, Vaibhav Bajaj, Shirley Zhang, Rebecca Braden, Pamela J. Schup-Magoffin, Oi Ling Kwan, Anthony N. DeMaria, Jennifer R. Cochran, Karen L. Christman

Institutions: University of California San Diego, Sanford Consortium for Regenerative Medicine, Stanford Cardiovascular Institute, Stanford University

Language: English

Topic: Cardiac Fibrosis and Remodeling

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: Engineered HGF-NK1 antagonists for Met-targeted cancer imaging and therapy, San Diego Clinical and Translational Research Institute, Extracellular Matrix Hydrogels for Treating Cardiomyopathy, UC San Diego Clinical and Translational Research Institute

OpenAlex ID: W1978788204

FWCI: 10.16

Cites: 47

Cited by: 100

Related to: 10